DEA Archived Press Releases

Press Releases before January 20, 2025
234 Results - Showing 21 to 30
PRESS RELEASE

Palomar Hospital Pays $250,000 for Diverting Fentanyl

SAN DIEGO – Palomar Health, a California public health care district located in San Diego County, has paid $250,000 to resolve allegations of diversion of fentanyl from one of its facilities and failure to keep accurate records for fentanyl. Palomar Health is California’s largest health care district, with campuses in...
PRESS RELEASE

Former Wallingford Doctor Who Sold Opioid Prescriptions for Cash Sentenced to Federal Prison

WALLINGFORD, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, announced that ANATOLY BRAYLOVSKY, 52, of Wallingford, hsa been sentenced by U.S. District Judge Kari A. Dooley in Bridgeport to 90 months of imprisonment, followed by three years of supervised release, for controlled substances and health...
PRESS RELEASE

Dark Web Drug Vendor and Clandestine Lab Manufacturer Sentenced to Prison for Trafficking in Meth and Fentanyl

MIAMI – On May 17, an Orange County, California, resident, Tenzin Orgil, 24, was sentenced to 168 months in federal prison for participating in a drug trafficking enterprise that included the sale of methamphetamine and fentanyl on the dark web, as well as the manufacture of ecstasy (also known as...
PRESS RELEASE

Success For DEA Rocky Mountain Field Division Prescription Drug Take Back Day

Thanks to community members, community partners, volunteers and members of the Drug Enforcement Administration’s Rocky Mountain Field Division (RMFD) the 26th National Prescription Drug Take Back Day was again a success. This past Saturday, often in challenging weather, people brought in their unneeded, unwanted or expired prescription medications to dozens...
PRESS RELEASE

Darknet Vendor Who Sold Millions of Fake Xanax Pills Sentenced

ST. LOUIS – U.S. District Judge Matthew T. Schelp on Wednesday sentenced a man who sold millions of counterfeit Xanax pills on the Darknet to two years in prison, fined him $10,000 and ordered him to forfeit nearly $1 million. Brandon Adams, 27, will also be on supervised release for...
PRESS RELEASE

DEA’s National Prescription Drug Take Back Day Enters 15th Year of Removing Unneeded Medications from Communities

El Paso – Together with its law enforcement partners, the Drug Enforcement Administration will host its 26th National Prescription Drug Take Back Day on Saturday, April 27, from 10 a.m. to 2 p.m. This event aims to remove unneeded prescriptions from homes to help prevent medication misuse by offering anonymous...
PRESS RELEASE

DEA Rocky Mountain Field Division Encourages Prescription Take Back This Saturday

The Drug Enforcement Administration’s Rocky Mountain Field Division (RMFD) is proud to be part of the 26th annual National Prescription Drug Take Back Day this Saturday, April 27, 2024 from 10:00am to 2:00pm MST at dozens of locations across Colorado, Utah, Wyoming and Montana. “DEA’s Take Back events serve as...
PRESS RELEASE

New Haven Pharmacy and Owner Agree to Pay $120,000 to Settle Controlled Substances Act Allegations

NEW HAVEN, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, and Stephen Belleau, Acting Special Agent in Charge of the Drug Enforcement Administration for New England, today announced that Cornerstone Pharmacy, Inc. (doing business as “Whalley Drug”), and its owner, YONG KWON, have entered into...
PRESS RELEASE

Seattle Man Sentenced for Buying 630,000 Counterfeit Pills on the Dark Web

ST. LOUIS – U.S. District Court Judge Stephen R. Clark on Thursday sentenced a man who bought 630,000 counterfeit Xanax and other pills on the dark web to five years in prison and ordered him to pay a $10,000 fine. Maximillian Gregory Verbowski will also be on supervised release for...
PRESS RELEASE

Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations

NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...